Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years.
Bloodstream infections
Haemodialysis
Mupirocin resistance
Staphylococcal carriage
Journal
The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
02
12
2022
revised:
11
01
2023
accepted:
21
01
2023
medline:
23
5
2023
pubmed:
23
2
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
Mupirocin-based decolonization of Staphylococcus aureus carriers undergoing haemodialysis is not widely implemented due to concerns of mupirocin resistance. In our haemodialysis unit, a strategy combining universal S. aureus screening with targeted mupirocin-based decolonization was introduced two decades ago. In this study of haemodialysis patients, mupirocin resistance was assessed in blood and colonizing S. aureus isolates during two periods. Mupirocin resistance in S. aureus was infrequent in both blood and colonizing isolates. Furthermore, in the years 2003-2021, a decreasing trend in the annual rate of S. aureus bloodstream infections was observed. Targeted mupirocin-based decolonization of S. aureus carriers undergoing haemodialysis is a sustainable measure for preventing healthcare-associated infections.
Identifiants
pubmed: 36805086
pii: S0195-6701(23)00046-4
doi: 10.1016/j.jhin.2023.01.019
pii:
doi:
Substances chimiques
Mupirocin
D0GX863OA5
Chlorhexidine
R4KO0DY52L
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-58Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.